Empowering Patients Through Education and Advocacy in Cancer Care
In the evolving landscape of healthcare, the role of the patient has shifted from a passive recipient of care
Site
Didn’t Expect That to Happen: Events That Must be Reported Promptly to the IRB
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
The Role of Data in Optimizing Clinical Trials: Key Insights for Sites and Sponsors
In the fast-evolving landscape of clinical research, data collection and performance metrics are indispensable tools for enhancing the efficiency
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
How Sites Can Win in the New Age of Genetically Engineered Treatments
With gene therapy trials on the rise, sites must prepare biosafety protocols, facility standards, and partnerships to attract cutting-edge studies.
Clinical Research in the COVID-19 Era: Methods for Continuity
The COVID-19 pandemic has led to a significant shift in day-to-day research operations. To keep research moving forward, sponsors need to build a solid foundation to support the virtualization of key components of clinical trials. In addition, the industry needs to maintain a participant-centric approach while ensuring participant safety and regulatory compliance throughout the trial.
EVAL Case Study with Case Comprehensive Cancer Center
Discover how the Case Comprehensive Cancer Center used Advarra EVAL to streamline CCSG workflows, improve data analysis, and show research ROI.